Derek Ansel

Derek Ansel, MS, CCRA has extensive experience in the field of clinical research, particularly in rare and orphan diseases. Derek has held various leadership roles at several renowned organizations, including Worldwide Clinical Trials, where they currently serve as the Executive Director and Therapeutic Strategy Lead for Rare Disease. Prior to this, Derek was the Senior Director and Director of Therapeutic Strategy Lead for Rare Disease at the same company.

Before joining Worldwide Clinical Trials, Derek worked at Synteract as the Director of Strategic Development for Rare, Orphan, and Pediatric Diseases. Derek also served as the Director of Rare and Orphan Diseases at the company.

At PRA Health Sciences, Derek gained experience as the Clinical Strategy Lead for the Center for Rare Diseases and as a Clinical Scientist in the same department.

Prior to their roles at PRA Health Sciences, Derek worked as a Senior Clinical Research Associate at Shire, a Clinical Research Associate II at ICON plc, and a Clinical Research Associate at PPD. At PPD, they were involved in a large multi-center HIV-1 clinical study and conducted site visits to ensure compliance with protocols and regulations. Derek also worked as a Scientist at PPD, where they performed assays, participated in assay development, and created and revised protocols and procedures.

Early in their career, Derek worked as a Biologist at Eurofins Lancaster Laboratories, where they performed viral plaque assays and analyzed outsourced data.

Derek Ansel, MS, CCRA has a strong educational background in the field of science and research. Derek obtained a Bachelor of Science degree in Cell/Cellular and Molecular Biology from West Chester University of Pennsylvania in 2010. Following that, they pursued a Master of Science degree in Pharmacology and Toxicology from Michigan State University, graduating in 2019. Currently, they are enrolled at Bay Path University, anticipated to complete a Master of Science degree in Genetic Counseling/Counselor in 2023. In addition to their academic achievements, Derek has also obtained certifications in Telegenetics from the Western States Regional Genetics Network in 2022 and Clinical Research from the Association of Clinical Research Professionals in 2017.